Novartis AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0012005267
CHF
107.24
1.26 (1.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Novartis AG stock-summary
stock-summary
Novartis AG
Pharmaceuticals & Biotechnology
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Coordinates stock-summary
Company Details
Lichtstrasse 35 , BASEL None : 4056
stock-summary
Tel: 41 61 3241111
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 15 Foreign Institutions (0.08%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Joerg Reinhardt
Independent Non-Executive Chairman of the Board
Dr. Enrico Vanni
Independent Non-Executive Vice Chairman of the Board
Ms. Bridgette Heller
Director
Dr. Simon Moroney
Director
Dr. Nancy Andrews
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
11,608 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,324 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 224,339 Million ()

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.29

stock-summary
Return on Equity

36.86%

stock-summary
Price to Book

6.36